Ad Hoc Disease Transmission Advisory Committee

The Ad Hoc Disease Transmission Advisory Committee (DTAC) considers issues related to the transmission of disease through organ transplantation. The Committee examines potential disease transmission cases reported to the OPTN in an effort to confirm transmissions where possible. It reviews aggregate data on cases to assess the risk of donor disease transmission in organ transplantation in the U.S. with the goal of providing (1) education and guidance to the transplant community toward preventing future disease transmission and (2) input in developing policy to improve the safety of organ donation through the reduction of donor derived transmission events. It may identify disease-transmission related patient safety issues to be addressed, as appropriate, by the OPTN.

Compiled by the Ad Hoc Disease Transmission Advisory Committee (DTAC), see the latest information known for minimizing the risk of donor-derived COVID-19 transmission while maximizing donor utilization. DTAC has committed to reviewing the document quarterly.

Current projects

Review

Implemented

  • Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates (6/2025)
  • Clarify Requirements for Reporting a Potential Disease Transmission (8/2025)
  • Standardize the Patient Safety Contact and Reduce Duplicate Reporting
  • Recognizing Seasonal and Geographically Endemic Infections in Organ Donors: Considerations during Deceased and Living Donor Evaluation
  • Require Lower Respiratory SARS-CoV-2 Testing for Lung Donors
  • Improve Deceased Donor Evaluation for Endemic Diseases
  • Pediatric Candidate Pre-Transplant HIV, HBV, and HCV Testing
  • Update Data Collection to Align with US Public Health Service Guideline 2020 (9/2023)
  • Align OPTN Policy with U.S. Public Health Service Guideline, 2020
  • Modify HOPE Act variance to include other organs (1/2019)
  • Require another match run based on infectious disease test results (1/2015)

Committee members

MembersOrganizationPositionEnd Term Date
Dr. Maheen AbidiMayo Clinic Hospital ArizonaAt Large6/30/2027
Oyedele AdeyiGeneral Public Region 7At Large6/30/2028
Dr. Pallavi D AnnambhotlaCenters for Disease Control & Prevention, HHSCDC Support6/30/2026
Dr. Sridhar V BasavarajuCenters for Disease Control & Prevention, HHSEx Officio (non voting)6/30/2026
Dr. Gerald J BerryGeneral Public Region 5At Large6/30/2027
Dr. Brandy K ClarkGeneral Public Region 2FDA Support6/30/2026
Dr. Lara Danziger-IsakovChildren's Hospital Medical CenterEx Officio6/30/2026
Dr. Cynthia FisherUniversity of Washington Medical CenterAt Large6/30/2026
Riki GravesGeneral Public Region 4At Large6/30/2027
Isabel GriffinCenters for Disease Control & Prevention, HHSCDC Support6/30/2026
Anna L HughartMayo Clinic Hospital MinnesotaAt Large6/30/2027
Dr. Shirish HuprikarMount Sinai Medical CenterAt Large6/30/2028
Jaskiran KaurSouthwest Transplant AllianceAt Large6/30/2026
Dr. Hanh KhuuGeneral Public Region 2FDA Support6/30/2026
Dr. Ian T KracalikCenters for Disease Control & Prevention, HHSEx Officio (non voting)6/30/2028
Dr. Dong Heun LeeUniversity of California San Francisco Medical CenterAt Large6/30/2027
Dr. Gabriel MaineHistocompatibility Laboratory at Corewell Health William Beaumont University HospitalAt Large6/30/2028
David McCormickCenters for Disease Control & Prevention, HHSEx Officio (non voting)6/30/2026
Kelsey McDavidCenters for Disease Control & Prevention, HHSEx Officio (non voting)6/30/2026
Dr. Marty T SellersGift of Life Donor ProgramAt Large6/30/2026
Tanvi SharmaBoston Children's HospitalAt Large6/30/2027
Fernanda SilveiraUniversity of Pittsburgh Medical CenterAt Large6/30/2028
Irma SisonGeneral Public Region 5Ex Officio6/30/2026
Dr. Helen S TeUniversity of Chicago Medical CenterAt Large6/30/2026
Dr. Anil J TrindadeVanderbilt University Medical CenterAt Large6/30/2026
Dr. Lorenzo N ZaffiriEmory University HospitalAt Large6/30/2026
Date Last Reviewed: